Study of EQ001 (Itolizumab) in Systemic Lupus Erythematosus With or Without Active Proliferative Nephritis

Conditions:   Lupus Erythematosus;   Lupus Nephritis Interventions:   Drug: Itolizumab [Bmab 600];   Drug: EQ001 Placebo Sponsors:   Equillium;   Biocon Limited Recruiting

Source: ClinicalTrials.gov - October 16, 2019 Category: Research Source Type: clinical trials